An SS-31 storage question cannot be answered reliably without identifying the finished preparation. The active-substance name alone does not establish the formulation, container, manufacturing controls or evidence supporting a storage limit.
The approved label describes a particular medicine
The Forzinity label includes storage and handling information for its specified solution and packaging. Those instructions are part of a defined product system. They cannot be transferred automatically to a different powder, solvent mixture or container.
Even if two labels use related ingredient terminology, the products may not share the same stability data. A forum rule about refrigeration therefore cannot establish that another preparation remains suitable for human use.
There is more than one way for a product to fail
Chemical stability, correct amount, contamination control and container suitability are separate questions. Showing that a particular analytical signal remains detectable does not demonstrate that every quality requirement has been met.
Likewise, clear appearance or an unchanged color is not a complete assessment. A person reporting that an old vial still seemed effective has not measured its contents, excluded contamination or established an acceptable risk profile.
This is why a useful storage claim identifies the exact tested preparation, conditions, duration, methods and acceptance criteria. Missing those details is not a small omission when the claim is being used to justify administration.
Who can answer a legitimate product question?
For prescribed Forzinity, use the current dispensing information and ask the pharmacist about any temperature excursion, unclear instruction or uncertainty about the container. Do not substitute an internet rule for product-specific advice.
For research-only material, this article supplies neither a preparation recipe nor a timetable that makes it suitable for injection. A shelf-life estimate cannot solve an unresolved human-use or product-identity problem.
The practical question is not simply how long a peptide molecule might persist. It is whether a defined finished medicine remains within its validated conditions of use. When the evidence does not identify that product, a confident universal number would be misleading.